The review presents data on new biomarkers for the diagnosis of rheumatoid arthritis, considers the diagnostic parameters of antibodies to carbamylated proteins, antibodies to peptidyl arginine deaminase, antibodies to homocysteinylated α1-antitrypsin, 14-3-3η, macrophage soluble scavenger receptor A. The use of new biomarkers can improve the diagnosis of RA in the early stages, as well as stratify patients based on the prognosis of the disease and provide a rational selection of therapy
Shuang Cui, Jie Qian Department of Rheumatology, Affiliated Hospital of Nantong University, Nantong,...
Background: Anti-carbamylated protein (anti-CarP) antibodies are present in patients with Rheumatoid...
Objective: To review the current and emerging auto-antibodies and biologic markers in rheumatoid art...
Current patient care in rheumatology relies primarily on a combination of traditional clinical asses...
which permits unrestricted use, distribution, and reproduction in any medium, provided the original ...
It has long been recognized that laboratory tests are useful in the diagnosis of disease and to moni...
The detection of RA in its early stages is often challenging, and the measurement of ACPA levels is ...
RA is a complex disease that develops as a series of events often referred to as disease continuum. ...
RA is a complex disease that develops as a series of events often referred to as disease continuum. ...
<p>Laboratory medicine in the early 21st century has achieved advances due to the development and pr...
With the development of understanding of the pathogenesis of rheumatoid arthritis, it has led to the...
Recent diagnostic advances allow to identify persons in a pre-symptomatic stage of rheumatoid arthri...
The diagnosis of rheumatoid arthritis (RA) is based on a combined approach that includes serological...
This review examines the biomarker development process by using rheumatic disorders as the disease m...
Biomarkers are important for guiding the clinical and therapeutic management of all phases of rheuma...
Shuang Cui, Jie Qian Department of Rheumatology, Affiliated Hospital of Nantong University, Nantong,...
Background: Anti-carbamylated protein (anti-CarP) antibodies are present in patients with Rheumatoid...
Objective: To review the current and emerging auto-antibodies and biologic markers in rheumatoid art...
Current patient care in rheumatology relies primarily on a combination of traditional clinical asses...
which permits unrestricted use, distribution, and reproduction in any medium, provided the original ...
It has long been recognized that laboratory tests are useful in the diagnosis of disease and to moni...
The detection of RA in its early stages is often challenging, and the measurement of ACPA levels is ...
RA is a complex disease that develops as a series of events often referred to as disease continuum. ...
RA is a complex disease that develops as a series of events often referred to as disease continuum. ...
<p>Laboratory medicine in the early 21st century has achieved advances due to the development and pr...
With the development of understanding of the pathogenesis of rheumatoid arthritis, it has led to the...
Recent diagnostic advances allow to identify persons in a pre-symptomatic stage of rheumatoid arthri...
The diagnosis of rheumatoid arthritis (RA) is based on a combined approach that includes serological...
This review examines the biomarker development process by using rheumatic disorders as the disease m...
Biomarkers are important for guiding the clinical and therapeutic management of all phases of rheuma...
Shuang Cui, Jie Qian Department of Rheumatology, Affiliated Hospital of Nantong University, Nantong,...
Background: Anti-carbamylated protein (anti-CarP) antibodies are present in patients with Rheumatoid...
Objective: To review the current and emerging auto-antibodies and biologic markers in rheumatoid art...